These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33834434)

  • 21. Moxifloxacin based fluorescence imaging of intestinal goblet cells.
    Lee S; Kim S; Nam K; Kim SY; Lee S; Myung SJ; Kim KH
    Biomed Opt Express; 2020 Oct; 11(10):5814-5825. PubMed ID: 33149988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections.
    Balfour JA; Lamb HM
    Drugs; 2000 Jan; 59(1):115-39. PubMed ID: 10718103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-Photon Microscopy of the Mouse Peripheral Cornea Ex Vivo.
    Lee JH; Kim KH; Lee S; Jeong H; Kim MJ
    Cornea; 2016 Nov; 35 Suppl 1():S31-S37. PubMed ID: 27631351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
    McCulley JP; Caudle D; Aronowicz JD; Shine WE
    Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of moxifloxacin (BAY 12-8039) in plasma and lung tissue by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method with a new polymeric cartridge.
    Lemoine T; Breilh D; Ducint D; Dubrez J; Jougon J; Velly JF; Saux MC
    J Chromatogr B Biomed Sci Appl; 2000 Jun; 742(2):247-54. PubMed ID: 10901129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain tumor delineation enhanced by moxifloxacin-based two-photon/CARS combined microscopy.
    Le VH; Yoo SW; Yoon Y; Wang T; Kim B; Lee S; Lee KH; Kim KH; Chung E
    Biomed Opt Express; 2017 Apr; 8(4):2148-2161. PubMed ID: 28736661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinically Significant Enhancement of Voriconazole Efficacy by Moxifloxacin and Gentamicin in Fungal Keratitis.
    Matoba AY; Divatia MK; Arguello RA; Chevez-Barrios P
    Cornea; 2018 May; 37(5):651-654. PubMed ID: 29489515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
    Kowalski RP; Dhaliwal DK; Karenchak LM; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state.
    Breilh D; Jougon J; Djabarouti S; Gordien JB; Xuereb F; Velly JF; Arvis P; Landreau V; Saux MC
    J Chemother; 2003 Dec; 15(6):558-62. PubMed ID: 14998080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
    Iannini PB
    Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrinsic cytotoxic effects of fluoroquinolones on human corneal keratocytes and endothelial cells.
    Bezwada P; Clark LA; Schneider S
    Curr Med Res Opin; 2008 Feb; 24(2):419-24. PubMed ID: 18157922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
    Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
    Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moxifloxacin (Avelox) for the treatment of bacterial skin infections.
    Parish LC; Witkowski JA; Routh HB
    Skin Therapy Lett; 2001 Oct; 6(11):1-2. PubMed ID: 11719825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols.
    Herrygers LA; Noecker RJ; Lane LC; Levine JM
    Cornea; 2005 Jan; 24(1):66-71. PubMed ID: 15604869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty.
    Fukuda M; Yamada M; Kinoshita S; Inatomi T; Ohashi Y; Uno T; Shimazaki J; Satake Y; Maeda N; Hori Y; Nishida K; Kubota A; Nakazawa T; Shimomura Y
    Adv Ther; 2012 Apr; 29(4):339-49. PubMed ID: 22529026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced penetration of moxifloxacin into rat prostate tissue evidenced by microdialysis.
    K Hurtado F; Laureano JV; de A Lock G; Derendorf H; Dalla Costa T
    Int J Antimicrob Agents; 2014 Oct; 44(4):327-33. PubMed ID: 25218157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of fluoroquinolones on mitochondrial function in pancreatic beta cells.
    Ghaly H; Jörns A; Rustenbeck I
    Eur J Pharm Sci; 2014 Feb; 52():206-14. PubMed ID: 24284031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitreous penetration of topical moxifloxacin and gatifloxacin in humans.
    Costello P; Bakri SJ; Beer PM; Singh RJ; Falk NS; Peters GB; Melendez JA
    Retina; 2006 Feb; 26(2):191-5. PubMed ID: 16467677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.
    Aliprandis E; Ciralsky J; Lai H; Herling I; Katz HR
    Cornea; 2005 Mar; 24(2):201-5. PubMed ID: 15725889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.